Global Information
회사소개 | 문의 | 비교리스트

미국의 조영제 및 방사성 의약품 시장 인사이트 : Medtech 360

Contrast Agents and Radiopharmaceuticals | Medtech 360 | Market Insights | US

리서치사 Clarivate
발행일 2021년 12월 상품코드 1054967
페이지 정보 영문 배송안내 1-2일 (영업일 기준)
가격
자세한 내용은 문의바랍니다.

미국의 조영제 및 방사성 의약품 시장 인사이트 : Medtech 360 Contrast Agents and Radiopharmaceuticals | Medtech 360 | Market Insights | US
발행일 : 2021년 12월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

미국의 조영제 및 방사성 의약품 시장 규모는 코로나19(COVID-19) 팬데믹에 의해 미국 영상 진단 시장에 큰 영향을 미쳤기 때문에 단기적으로는 영향을 받을 것으로 예상됩니다. 그러나, 시장이 안정되면 고령화 진전, 흐트러진 생활습관 등의 건강 위험요인 증가 및 유리한 규제 변경에 따른 신기술 채택 등을 배경으로 2029년까지 완만한 성장이 전망되고 있습니다. CEUS와 PET 검사에서의 영상 진단약 사용 확대가 시장 성장에 기여할 것으로 예상됩니다.

미국의 조영제(Contrast Agents) 및 방사성 의약품(Radiopharmaceuticals) 시장을 조사했으며, COVID-19의 영향, 시장 성장 촉진요인, 제품 부문 예측 등 10년간의 종합적 데이터와 분석 등의 정보를 제공합니다.

목차

미국

개요

요약

  • COVID-19 업데이트
  • 시장 하이라이트
  • 경쟁 하이라이트
  • 시장 동향
  • 대상 검사와 대상 제품

주요 보고서 업데이트

COVID-19 분석

  • 시장에 대한 영향
  • 주요 시장 예측 변화와 전제조건
  • 경쟁의 영향

조영제 및 방사성 의약품 시장

  • 시장 하이라이트
  • 시장의 정의
  • 시장 예측 데이터
  • 경쟁 하이라이트
  • 시장 점유율
  • 경쟁 요인과 전략
    • 규제 환경
    • 가격 전략과 구입 옵션
    • 인수합병(M&A) 및 파트너십
    • 부정적인 보도
    • 대체 제품과의 경쟁
    • 시장 어필
    • 제품 개선과 혁신
  • 시장 동향

방사성 의약품 시장

  • 시장 하이라이트
  • 시장의 정의
  • 시장 예측 데이터
  • 경쟁 하이라이트
  • 시장 점유율
  • 경쟁 요인과 전략

CT/X선 조영제 시장

  • 시장 하이라이트
  • 시장의 정의
  • 시장 예측 데이터
  • 경쟁 하이라이트
  • 시장 점유율
  • 경쟁 요인과 전략

MRI 조영제 시장

  • 시장 하이라이트
  • 시장의 정의
  • 시장 예측 데이터
  • 경쟁 하이라이트
  • 시장 점유율
  • 경쟁 요인과 전략
    • 부정적인 보도
    • 제품 개선과 혁신

초음파 조영제 시장

  • 시장 하이라이트
  • 시장의 정의
  • 시장 예측 데이터
  • 경쟁 하이라이트
  • 시장 점유율
  • 경쟁 요인과 전략

부록

  • 약어
  • 참고 문헌

조사 방법

  • 핵심국 조사 방법
  • 조사 방법
  • Marketrack의 조사 방법
  • PriceTrack의 조사 방법
  • 예측 조사 방법
  • 준주요국가 조사 방법
  • 기준 연비율 분석
  • 시장 예측
LSH 22.03.07

The COVID-19 pandemic will have a significant impact on the US diagnostic imaging market in the short term. Once the market stabilizes, however, the contrast agents and radiopharmaceuticals market in US will see modest growth through 2029 driven by a growing aging population, increases in health risk factors like poor lifestyle, and adoption of new technology due to favorable regulatory changes. However, overall market expansion will be hindered by a saturated installed base of large imaging systems as well as consolidation of hospitals.

Growth in the US market for contrast agents and radiopharmaceuticals will be driven by the expanded use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by the continued concern over gadolinium and radiation exposure in certain modalities, while the shift to value-based care will hinder the use of some procedures while supporting the use of those that provide the most accuracy and clarity of visualization.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in the US across a 10-year period.

The COVID-19 pandemic will affect the diagnostic imaging system market.

  • To what extent will the COVID-19 pandemic impact the US diagnostic imaging system market?
  • How will the impact of the COVID-19 pandemic differ between segments?
  • How quickly are procedure volumes expected to rebound?

The FDA recently expanded approval for the use of CEUS in radiology procedures.

  • What types of procedures does this approval extend to? Which additional procedures could be approved in the future?
  • Which contrast agents received FDA approval?
  • How will competitors that do not have FDA approval react?

Looming concerns over the effects of gadolinium retention will negatively affect the use of contrast-enhanced MRI.

  • How are ACOs, health networks, and physicians responding to the recent findings on gadolinium retention?
  • What are the key differences between linear and macrocyclic GBCAs, and how will market demand for these products shift going forward?
  • Will other imaging modalities cannibalize contrast-enhanced MRI procedures?

While less concerning than in the past, radiation dose concerns still exert a limiting effect on procedure volumes for some imaging modalities.

  • How are US radiologists responding, and what methods are they using to ensure image quality?
  • Which procedures are being cannibalized by other modalities that do not require radiation for image acquisition?

The SPECT radiopharmaceuticals industry is taking precautionary measures to insulate itself from the shortening supply of Mo-99 and Tc-99.

  • What novel technology is showing promise that could help with global supply of Tc-99?
  • How will the transition from HEU to LEU reactors affect ASPs in the US market?

Table of Contents

United States

Abstract

Executive Summary

  • COVID-19 Updates
  • Market Highlights
  • Competitive Highlights
  • Market Developments
  • Procedures and Products Covered

Key Report Updates

COVID-19 Analysis

  • Market Impact
  • Major Market Forecast Changes and Assumptions
  • Competitive Impact

Contrast Agent and Radiopharmaceutical Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • Regulatory Environment
    • Pricing Strategies and Purchasing Options
    • Mergers, Acquisitions, and Partnerships
    • Negative Press
    • Competition from Alternatives
    • Market Appeal
    • Product Improvements and Innovations
  • Market Developments

Radiopharmaceutical Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

CT and X-Ray Contrast Agent Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

MRI Contrast Agent Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies
    • Negative Press
    • Product Improvements and Innovations

Ultrasound Contrast Agent Market

  • Market Highlights
  • Market Definitions
  • Market Forecast Data
  • Competitive Highlights
  • Market Shares
  • Competitive Factors and Strategies

Appendix

  • Abbreviations
  • Bibliography

Methodology

  • Core Country Coverage Methodology
  • Research Methodology
  • Marketrack Methodology
  • PriceTrack Methodology
  • Forecast Methodology
  • Supplemental Country Coverage Methodology
  • Base-Year Ratio Analysis
  • Market Forecasting

Tables and Figures

  • Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2030
  • Contrast Agent and Radiopharmaceutical Market Landscape, US (USD), 2020 and 2030
  • Competitive Factors and Strategies, by Product Type, US
  • Contrast Agent and Radiopharmaceutical Market Share Rankings, by Product Type, US, 2020
  • Companies Mentioned
  • Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
  • Contrast Agent and Radiopharmaceutical Procedures and Products Covered, US
  • COVID-19 Impact Assessment Summary, Contrast Agent and Radiopharmaceutical Market, US
  • Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2030 (Excluding COVID-19 Impact)
  • Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2030 (Including COVID-19 Impact)
  • COVID-19 Competitive Factors and Strategies, Contrast Agent and Radiopharmaceutical Market, US
  • COVID-19 Financial Impact and Competitor Insights
  • Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, US
  • Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2030
  • Contrast Agent and Radiopharmaceutical Procedures, by Product Type, US, 2019-2030
  • Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2030
  • Contrast Agent and Radiopharmaceutical Revenue Market Shares, US, 2020
  • Contrast Agent and Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2020
  • Competitive Factors and Strategies, by Product Type, US
  • Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
  • Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
  • Radiopharmaceutical Market, by Product Type, US (USD), 2019-2030
  • Radiopharmaceutical Market, by Product Type, US (USD), 2019-2030
  • Radiopharmaceutical Market Growth, by Product Type, US, 2020-2030
  • Nuclear Medicine System Installed Base, by Product Type, US, 2019-2030
  • Radiopharmaceutical Revenue Market Shares, US, 2020
  • Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2020
  • Competitive Factors and Strategies, US
  • CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2030
  • CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2030
  • CT and X-Ray Contrast Agent Market Growth, by Product Type, US, 2020-2030
  • CT and X-Ray System Installed Base, by Product Type, US, 2019-2030
  • CT Contrast Agent Market, by Procedure Type, US (USD), 2019-2030
  • CT Contrast Agent Market Growth, by Procedure Type, US, 2020-2030
  • CT and X-Ray Contrast Agent Revenue Market Shares, US, 2020
  • CT and X-Ray Contrast Agent Revenue Market Shares, US, 2020
  • Competitive Factors and Strategies, US
  • MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2030
  • MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2030
  • MRI Contrast Agent Market Growth, by Procedure Type, US, 2020-2030
  • MRI System Installed Base, US, 2019-2030
  • MRI Contrast Agent Revenue Market Shares, US, 2020
  • MRI Contrast Agent Revenue Market Shares, US, 2020
  • Competitive Factors and Strategies, US
  • Ultrasound Contrast Agent Market, US (USD), 2019-2030
  • Ultrasound Contrast Agent Market, US (USD), 2019-2030
  • Ultrasound Contrast Agent Revenue Market Shares, US, 2020
  • Ultrasound Contrast Agent Revenue Market Shares, US, 2020
  • Competitive Factors and Strategies, US
  • Abbreviations
Back to Top
전화 문의
F A Q